WATERTOWN, Mass.--(BUSINESS WIRE)--Healthcare policy reform, the global economic crisis, and large pharmas’ imminent patent cliff have converged creating a demand for new talent, local and international, to expedite research and development initiatives. Requiring an ongoing investment in global scientific education, the biopharmaceutical industry must establish and facilitate a connection with fresh talent through educational mediums that promote and harbor scientific curiosity. In doing so, the industry reasserts its focus on continual innovation in worldwide research and development capabilities.
